HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rajita Sinha Selected Research

Cocaine-Related Disorders (Cocaine Addiction)

10/2017Sex differences in guanfacine effects on stress-induced stroop performance in cocaine dependence.
3/2016Effects of progesterone stimulated allopregnanolone on craving and stress response in cocaine dependent men and women.
1/2014The role of guanfacine as a therapeutic agent to address stress-related pathophysiology in cocaine-dependent individuals.
9/2013The effects of exogenous progesterone on drug craving and stress arousal in cocaine dependence: impact of gender and cue type.
8/2013The clinical neurobiology of drug craving.
4/2013Error processing and gender-shared and -specific neural predictors of relapse in cocaine dependence.
11/2012Enhanced midbrain response at 6-month follow-up in cocaine addiction, association with reduced drug-related choice.
7/2012Guanfacine effects on stress, drug craving and prefrontal activation in cocaine dependent individuals: preliminary findings.
4/2012Neural correlates of stress-induced and cue-induced drug craving: influences of sex and cocaine dependence.
12/2011Deficits in default mode network activity preceding error in cocaine dependent individuals.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rajita Sinha Research Topics

Disease

30Alcoholism (Alcohol Abuse)
01/2022 - 02/2002
26Cocaine-Related Disorders (Cocaine Addiction)
10/2017 - 03/2005
24Substance-Related Disorders (Drug Abuse)
08/2019 - 08/2003
8Obesity
11/2017 - 10/2011
6Substance Withdrawal Syndrome (Withdrawal Symptoms)
01/2022 - 04/2007
6Insulin Resistance
11/2021 - 01/2013
5Wounds and Injuries (Trauma)
11/2021 - 05/2005
5Opioid-Related Disorders (Opiate Addiction)
11/2019 - 02/2002
4Weight Gain
01/2017 - 01/2013
4Marijuana Abuse (Cannabis Abuse)
01/2013 - 12/2005
2Hyperglycemia
01/2020 - 01/2018
2Hypoglycemia (Reactive Hypoglycemia)
01/2018 - 10/2011
2Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
07/2015 - 01/2015
2Pediatric Obesity
03/2015 - 11/2014
2Hyperphagia (Overeating)
03/2015 - 10/2011
2Nausea
01/2015 - 02/2002
1Cardiovascular Diseases (Cardiovascular Disease)
10/2022
1Autoimmune Hepatitis
05/2022
1Parkinson Disease (Parkinson's Disease)
01/2022
1Anxiety Disorders (Anxiety Disorder)
01/2020
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2020
1Tobacco Use Disorder (Nicotine Dependence)
01/2017
1Bulimia (Binge Eating)
04/2016
1Body Weight (Weight, Body)
03/2016
1Gambling (Pathological Gambling)
01/2016
1Cognitive Dysfunction
03/2015
1Bipolar Disorder (Manic Depressive Psychosis)
09/2012
1Inflammation (Inflammations)
03/2012
1Atrophy
10/2011
1Overweight
02/2011
1Memory Disorders (Memory Loss)
09/2009
1Pain (Aches)
04/2008
1Feeding and Eating Disorders (Eating Disorder)
04/2007
1Antisocial Personality Disorder (Antisocial Personality)
02/2006
1Mental Disorders (Mental Disorder)
08/2005

Drug/Important Bio-Agent (IBA)

32Cocaine (Cocaine HCl)IBA
01/2019 - 03/2005
30Pharmaceutical PreparationsIBA
02/2019 - 08/2003
8Hydrocortisone (Cortisol)FDA LinkGeneric
11/2021 - 09/2009
6Biomarkers (Surrogate Marker)IBA
01/2022 - 12/2009
6Prazosin (Minipress)FDA LinkGeneric
01/2022 - 02/2012
6Naltrexone (ReVia)FDA LinkGeneric
11/2019 - 02/2002
5CytokinesIBA
05/2022 - 03/2012
5Glucose (Dextrose)FDA LinkGeneric
01/2018 - 10/2011
3Biological ProductsIBA
10/2022 - 01/2012
3Adrenocorticotropic Hormone (ACTH)FDA Link
11/2021 - 03/2015
3Hypoglycemic Agents (Hypoglycemics)IBA
01/2020 - 10/2011
3Opioid Analgesics (Opioids)IBA
11/2019 - 04/2007
3NicotineFDA Link
01/2019 - 07/2011
3Guanfacine (Tenex)FDA LinkGeneric
10/2017 - 10/2013
3GhrelinIBA
01/2017 - 03/2015
3ProgesteroneFDA LinkGeneric
03/2016 - 09/2013
3FructoseIBA
01/2016 - 01/2013
2Interleukin-6 (Interleukin 6)IBA
11/2020 - 01/2020
2Adrenergic Agonists (Adrenergic Receptor Agonist)IBA
11/2019 - 05/2014
2NeurosteroidsIBA
01/2019 - 03/2016
2GlucocorticoidsIBA
11/2018 - 08/2017
2LeptinIBA
01/2017 - 11/2014
2Hormones (Hormone)IBA
01/2017 - 05/2013
2Insulin (Novolin)FDA Link
01/2017 - 02/2013
2Dopamine (Intropin)FDA LinkGeneric
05/2015 - 11/2012
2Brain-Derived Neurotrophic Factor (BDNF)IBA
05/2012 - 10/2011
1Indicators and Reagents (Reagents)IBA
01/2021
1phosphatidylethanolIBA
01/2021
1Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
11/2020
1Adrenergic Agents (Adrenergic Drugs)IBA
01/2020
1lofexidineIBA
11/2019
1adenylyl- (3'- 5')- cytidylyl- (3'- 5')- cytidine (r(ACC))IBA
08/2019
1Methamphetamine (Desoxyn)FDA LinkGeneric
01/2019
1nasIBA
01/2019
1Blood Glucose (Blood Sugar)IBA
01/2018
1FatsIBA
01/2017
1CarbohydratesIBA
01/2017
1CannabidiolIBA
05/2015
1CRF receptor type 1IBA
03/2015
1pexacerfontIBA
03/2015
1acyl-ghrelinIBA
03/2015
1Aprepitant (Emend)FDA Link
01/2015
1Neurokinin-1 Receptor AntagonistsIBA
01/2015
1Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA
02/2014
1CannabinoidsIBA
12/2012
1CB1 Cannabinoid Receptor (CB1 Receptor)IBA
12/2012
1LithiumIBA
09/2012
1Neuropeptide YIBA
04/2012
1Serotonin (5 Hydroxytryptamine)IBA
05/2010
15-HT1B Serotonin ReceptorIBA
05/2010
1Gonadal Steroid Hormones (Sex Hormones)IBA
01/2008
1Neurotransmitter Agents (Neurotransmitter)IBA
08/2005
1Narcotic Antagonists (Opioid Antagonists)IBA
02/2002

Therapy/Procedure

6Therapeutics
03/2015 - 10/2006
2Psychotherapy Imagery (Guided Imagery)
07/2015 - 02/2011
2Drug Therapy (Chemotherapy)
01/2015 - 04/2009
1Neurofeedback
01/2022
1Secondary Prevention
11/2019